Elimination of rubella and prevention of congenital rubella infection in Europe has been a high priority for the WHO European Regional Office over the past decade. In 2010 the WHO regional committee for Europe renewed its commitment to the elimination of rubella and prevention of CRS with a new target of 2015. For Central Europe to reach the target of rubella elimination and prevention of CRS by 2015, very high vaccine coverage levels need to be maintained and catch-up campaigns continued to address susceptible groups, in particular women of child-bearing age. 

​The goal of eliminating rubella and preventing CRS by 2015 could be achieved and maintained adopting a comprehensive approach to ensure high vaccination coverage.

This review shows that doctors and other healthcare providers are regarded as the most reliable sources of information from parents

This large population based sero-epidemiological study describes MMR seroprevalence as a whole and calculates independent predictors for seronegativity for measles, mumps and rubella antibodies in Germany.

​The summary of the the first intercountry meeting, held in Copenhagen on 24-25 March 2015, hosted jointly by WHO/Europe and the European Centre for Disease Prevention and Control (ECDC) to address issues encountered by the national verfication committeees in European Union (EU)/European Economic Area (EEA) Member States.

​​3 969 cases of measles were reported by 30 EU/EEA countries from 1 January to 31 December 2015, according to ECDC’s latest measles and rubella monitoring report. One measles-related death was reported in a 19 month old child, and six cases were complicated by acute measles encephalitis.

ECDC and WHO Europe jointly release “MESSAGE - MEaSles and rubella Self Assessment GEnerating tool” for public health experts, to facilitate assessment of the progress made towards measles and rubella elimination.